Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Therapy of castration-resistant prostate cancer].
Rauchenwald M, Bauernhofer T, De Santis M, Füreder T, Höltl W, Kramer G, Krause S, Loidl W, Oismüller R, Reissigl A, Schmeller N, Stackl W, Stoiber F, Krainer M. Rauchenwald M, et al. Among authors: bauernhofer t. Wien Klin Wochenschr. 2012 Aug;124(15-16):538-51. doi: 10.1007/s00508-012-0206-1. Epub 2012 Jul 20. Wien Klin Wochenschr. 2012. PMID: 22815001 German.
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For.
Bonstingl L, Skofler C, Ulz C, Zinnegger M, Sallinger K, Schönberger J, Schuch K, Pankratz K, Borrás-Cherrier A, Somodi V, Abuja PM, Oberauner-Wappis L, Moser T, Heitzer E, Bauernhofer T, Kroneis T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Clin Chem. 2024 Sep 3;70(9):1140-1150. doi: 10.1093/clinchem/hvae079. Clin Chem. 2024. PMID: 38958115
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Barth DA, Moik F, Steinlechner S, Posch F, Mayer MC, Sandner AM, Berton F, Schlintl V, Koch L, John N, Wurm R, Pichler M, Bauernhofer T, Reimann P, Wohlkönig C, Richtig E, Winder T, Preusser M, Jost PJ, Ay C, Gerger A, Terbuch A, Riedl JM. Barth DA, et al. Among authors: bauernhofer t. J Immunother Cancer. 2023 Dec 14;11(12):e007765. doi: 10.1136/jitc-2023-007765. J Immunother Cancer. 2023. PMID: 38097343 Free PMC article.
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels.
Pelzmann B, Hatab A, Scheruebel S, Langthaler S, Rienmueller T, Sokolowski A, Gorischek A, Platzer D, Zorn-Pauly K, Jahn SW, Bauernhofer T, Schreibmayer W. Pelzmann B, et al. Among authors: bauernhofer t. Front Oncol. 2022 Oct 31;12:998907. doi: 10.3389/fonc.2022.998907. eCollection 2022. Front Oncol. 2022. PMID: 36483038 Free PMC article.
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Fluhrer H, Hutterer GC, Golbeck S, Stidl M, Niedrist T, Pichler R, Mischinger J, Seles M, Mannweiler S, Spiegelberg J, Bauernhofer T, Jost PJ, Ahyai S, Zigeuner R, Pichler M, Barth DA. Fluhrer H, et al. Among authors: bauernhofer t. Ther Adv Med Oncol. 2022 Nov 19;14:17588359221134065. doi: 10.1177/17588359221134065. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36425872 Free PMC article.
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
Egger V, Hutterer GC, Mischinger J, Seles M, Pichler R, Mannweiler S, Huber K, Balihodzic A, Spiegelberg J, Bauernhofer T, Ahyai S, Zigeuner R, Pichler M, Barth DA. Egger V, et al. Among authors: bauernhofer t. World J Urol. 2023 May;41(5):1359-1364. doi: 10.1007/s00345-023-04379-y. Epub 2023 Apr 6. World J Urol. 2023. PMID: 37024555 Free PMC article.
Correction: Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay.
Bonstingl L, Zinnegger M, Sallinger K, Pankratz K, Müller CT, Pritz E, Odar C, Skofler C, Ulz C, Oberauner-Wappis L, Borrás-Cherrier A, Somođi V, Heitzer E, Kroneis T, Bauernhofer T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Biomark Res. 2024 Dec 2;12(1):150. doi: 10.1186/s40364-024-00698-3. Biomark Res. 2024. PMID: 39617911 Free PMC article. No abstract available.
123 results